Breakthrough in Sustainable Electronics Manufacturing Electrical engineers at Duke University have achieved a significant milestone in sustainable electronics by developing…
Circle Pharma will present promising preclinical data on its first-in-class oral macrocyclic cyclin D1-selective inhibitors at the upcoming AACR-NCI-EORTC conference. The company’s innovative approach targets cyclin D1-driven cancers through selective disruption of the cyclin D1-Rb interaction.
Circle Pharma, a clinical-stage biopharmaceutical company focused on developing targeted macrocycle therapeutics, has announced an upcoming poster presentation highlighting the significant anti-tumor potential of cyclin D1 RxL inhibition. The presentation will occur at the prestigious AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston from October 22-26, 2025.
A groundbreaking NTNU study shows most plastic pollution measures focus on cleanup rather than addressing root causes. Researchers identify only three approaches capable of creating meaningful systemic change in production and consumption patterns.
Despite numerous initiatives to combat plastic pollution in Norway, a comprehensive study from the Norwegian University of Science and Technology reveals that only a handful of approaches will lead to substantial environmental improvement. With millions of tons of plastic entering marine ecosystems annually, researchers are seeking solutions that address the problem at its source rather than merely cleaning up the consequences.
